Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
21 participants
INTERVENTIONAL
2014-06-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Technical Evaluation Of JewelPUMP In Type 1 Diabetic Patients Treated With Extern Insulin Pump
NCT01640210
Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump
NCT05299177
Creation of a Patient Database for Silicon Patient Simulation, Glucose Sensor Variability and Pharmacokinetic Study of Debiotech Jewelpump
NCT01640223
Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control
NCT02627911
Omnipod 5 System Compared to Pump Therapy
NCT05409131
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will be conduct with 15 patients at the following investigation centers : Corbeil Hospital, CHU of Strasbourg, and CHRU of Marseille.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
JewelPump
JewelPump for the first treatment period followed by the usual pump for the second treatment period
JewelPump
usual insulin pump
Usual insulin pump
Patients in the arm 2, will have the usual insulin pump for the first treatment period, followed with the second period which they will have the JewelPump.
JewelPump
usual insulin pump
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
JewelPump
usual insulin pump
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with HbA1c \< 8.5%
* Patients who signed consent
Exclusion Criteria
* Patients who have all serious diseases that could interfere with the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvia FRANC, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Sud Francilien
Nathalie JEANDIDIER, Pr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Strasbourg, France
Denis RACCAH, Pr.
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Marseille
Guillaume CHARPENTIER, MD
Role: STUDY_CHAIR
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Sud Francilien
Évry, , France
CHU Marseille-Hôpital Nord
Marseille, , France
CHU Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A00792-43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.